Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Hoon Sim

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Clinical Breast Cancer|June 30, 2018
Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation ThresholdYunju Kim, Sung Hoon Sim, Boram Park, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2021
Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO studyJae Ho Jeong, Jeong Eun Kim, Jin-Hee Ahn, et al.
Frontiers in Oncology|November 22, 2021
Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast CancerTae Hyun Kim, Keun Seok Lee, Sung Hoon Sim, et al.
Molecular Metabolism|August 23, 2025
ACAA1 knockout increases the survival rate of KPC mice by activating autophagyHo Lee, Mingyu Kang, Sung Hoon Sim, et al.
International Journal of Cancer|April 27, 2021
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancerHyehyun Jeong, Jae Ho Jeong, Jeong Eun Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|December 27, 2008
Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinomaSung Hoon Sim, Sae-Won Han, Do-Youn Oh, et al.
Annals of Translational Medicine|March 14, 2022
Targeted next generation sequencing of circulating tumor DNA provides prognostic information for management in breast cancer patientsHyoeun Shim, Min Jeong Kwon, In Hae Park, et al.
Scientific Reports|January 13, 2021
Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging studyYunju Kim, Sung Hoon Sim, Boram Park, et al.
Breast Cancer Research and Treatment|March 9, 2018
Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assaySoo Jin Park, Moo Hyun Lee, Sun-Young Kong, et al.
JMIR Mhealth and Uhealth|September 24, 2025
Impact of a 24-Week Mobile App-Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort StudyEun-Gyeong Lee, Dong-Eun Lee, Jeongseon Kim, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Clinical Breast Cancer|June 30, 2018
Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation ThresholdYunju Kim, Sung Hoon Sim, Boram Park, et al.
European Journal of Cancer (Oxford, England : 1990)|January 3, 2021
Leuprorelin combined with letrozole with/without everolimus in ovarian-suppressed premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: The LEO studyJae Ho Jeong, Jeong Eun Kim, Jin-Hee Ahn, et al.
Frontiers in Oncology|November 22, 2021
Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast CancerTae Hyun Kim, Keun Seok Lee, Sung Hoon Sim, et al.
Molecular Metabolism|August 23, 2025
ACAA1 knockout increases the survival rate of KPC mice by activating autophagyHo Lee, Mingyu Kang, Sung Hoon Sim, et al.
International Journal of Cancer|April 27, 2021
Final results of the randomized phase 2 LEO trial and bone protective effects of everolimus for premenopausal hormone receptor-positive, HER2-negative metastatic breast cancerHyehyun Jeong, Jae Ho Jeong, Jeong Eun Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|December 27, 2008
Erlotinib after Gefitinib failure in female never-smoker Asian patients with pulmonary adenocarcinomaSung Hoon Sim, Sae-Won Han, Do-Youn Oh, et al.
Annals of Translational Medicine|March 14, 2022
Targeted next generation sequencing of circulating tumor DNA provides prognostic information for management in breast cancer patientsHyoeun Shim, Min Jeong Kwon, In Hae Park, et al.
Scientific Reports|January 13, 2021
Criteria for identifying residual tumours after neoadjuvant chemotherapy of breast cancers: a magnetic resonance imaging studyYunju Kim, Sung Hoon Sim, Boram Park, et al.
Breast Cancer Research and Treatment|March 9, 2018
Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assaySoo Jin Park, Moo Hyun Lee, Sun-Young Kong, et al.
JMIR Mhealth and Uhealth|September 24, 2025
Impact of a 24-Week Mobile App-Based Human Coaching Program on Body Composition and Lipid Metabolism in Breast Cancer Survivors With Overweight or Obesity: Single-Arm Prospective Cohort StudyEun-Gyeong Lee, Dong-Eun Lee, Jeongseon Kim, et al.
Pageof 8